Concepedia

Publication | Open Access

Class III β-Tubulin Overexpression Is a Marker of Poor Clinical Outcome in Advanced Ovarian Cancer Patients

DOIFull Paper Access

218

Citations

31

References

2006

Year

Gabriella Ferrandina, Gian Franco Zannoni, Enrica Martinelli, Amelia Paglia, Valerio Gallotta, Simona Mozzetti, Giovanni Scambia, Cristiano Ferlini
Clinical Cancer Research

Abstract

Assessment of beta III tubulin could be useful to identify poor prognosis ovarian cancer patients candidates to more aggressive and/or targeted therapy.

References

YearCitations

Page 1